source
- FDA to discontinue pilot program aimed at preventing drug production issuesThe U.S. Food and Drug Administration announced it will end a pilot program that was created to help drug manufacturers address production problems before they arise. The initiative, which ran for…
- GSK secures FDA approval for lung-cancer drug Jideytro after $10.6 billion Nuvalent acquisitionGSK received FDA clearance for Jideytro, a therapy for patients with metastatic non‑small cell lung cancer that have ROS1 gene alterations and have already been treated with another targeted drug.…